Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

Published:2013-01 Issue:1 Volume:52 Page:175-191
ISSN:0163-7827
Container-title:Progress in Lipid Research
language:en
Short-container-title:Progress in Lipid Research

Author:

Musso Giovanni,Gambino Roberto,Cassader Maurizio

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference133 articles.

1. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the american association for the study of liver diseases;Chalasani;Am College Gastroenterol, Am Gastroenterol Assoc Hepatol,2012

2. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States;Charlton;Gastroenterology,2011

3. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity;Musso;Ann Med,2011

4. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis;Tilg;Hepatology,2010

5. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites;Neuschwander-Tetri;Hepatology,2010

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics;Livers;2024-09-13

2. Modulation of liver cholesterol homeostasis by choline supplementation during fibrosis resolution;Heliyon;2024-09

3. Regulation of transcription factor function by purinergic signalling in cardiovascular diseases;Purinergic Signalling;2024-08-31

4. RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives;International Journal of Molecular Sciences;2024-08-24

5. Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets;Journal of Clinical and Experimental Hepatology;2024-07